91 related articles for article (PubMed ID: 7574103)
1. [Antiplatelet glycoprotein monoclonal antibodies: properties and practical value].
Saffroy R; Bachelot C; Rendu F
Ann Biol Clin (Paris); 1995; 53(3):97-105. PubMed ID: 7574103
[TBL] [Abstract][Full Text] [Related]
2. Activation of human platelets by monoclonal antibodies.
Perutelli P; Mori PG
Haematologica; 1993; 78(3):172-7. PubMed ID: 8375747
[TBL] [Abstract][Full Text] [Related]
3. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
4. [Detection of circulating activated platelets by anti-GMP-140 monoclonal antibodies].
Tanoue K; Akamatsu N; Suzuki H; Katagiri Y; Yamazaki H; Fujimoto T; Fukuda S; Onozawa Y
Nihon Rinsho; 1992 Feb; 50(2):330-5. PubMed ID: 1377293
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human platelet IgG Fc receptor associated with membrane glycoprotein.
Shido K; Ahmad G; Hsu L; Kamiyama M
J Clin Lab Immunol; 1995; 46(1):1-11. PubMed ID: 9363587
[TBL] [Abstract][Full Text] [Related]
6. CD36 is spatially associated with glycoprotein IIb-IIIa (alpha IIb beta 3) on the surface of resting platelets.
Dorahy DJ; Berndt MC; Shafren DR; Burns GF
Biochem Biophys Res Commun; 1996 Jan; 218(2):575-81. PubMed ID: 8561798
[TBL] [Abstract][Full Text] [Related]
7. Role of Fc gamma RIIA gene polymorphism in human platelet activation by monoclonal antibodies.
Bachelot C; Saffroy R; Gandrille S; Aiach M; Rendu F
Thromb Haemost; 1995 Dec; 74(6):1557-63. PubMed ID: 8772237
[TBL] [Abstract][Full Text] [Related]
8. Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (Fc gamma RII).
Rubinstein E; Kouns WC; Jennings LK; Boucheix C; Carroll RC
Br J Haematol; 1991 May; 78(1):80-6. PubMed ID: 1828363
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of GPIIb- and GPIIIa-specific monoclonal antibodies. Further evidence for the existence of agonist-specific activated states of the platelet fibrinogen receptor.
de Castellarnau C; Cullaré C; Alvarez MV; Muñiz-Diez E; Calzada MJ; González-Rodríguez J
Platelets; 1997; 8(4):243-53. PubMed ID: 16793655
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic map of the N-terminal domain of the GPIIIa subunit of the human platelet fibrinogen receptor (GPIIb-IIIa) determined in vivo by monoclonal, immunochemical inhibition of acute arterial thrombosis.
Escudero C; Alvarez MV; de Haro J; Alvarez L; Millán I; Castillo-Olivares JL; González-Rodríguez J
Platelets; 1997; 8(5):349-54. PubMed ID: 16793667
[TBL] [Abstract][Full Text] [Related]
11. Clues for understanding the structure and function of a prototypic human integrin: the platelet glycoprotein IIb/IIIa complex.
Calvete JJ
Thromb Haemost; 1994 Jul; 72(1):1-15. PubMed ID: 7974356
[TBL] [Abstract][Full Text] [Related]
12. Evidence that the arg1744 gly1745 asp1746 sequence in the GPIIb-IIIa-binding domain of von Willebrand factor is involved in platelet adhesion and thrombus formation on subendothelium.
Weiss HJ; Hoffmann T; Yoshioka A; Ruggeri ZM
J Lab Clin Med; 1993 Sep; 122(3):324-32. PubMed ID: 8409708
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against platelet membrane glycoproteins IIb/IIIa and Ibalpha inhibit platelet dependent thrombin generation by different mechanisms.
Thomas S; Metcalfe P; Goodall AH; Gray E
Thromb Haemost; 2000 Jul; 84(1):98-103. PubMed ID: 10928478
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to platelet glycoproteins Ib and IIb/IIIa inhibit adhesion of platelets to purified solid-phase von Willebrand factor.
Danton MC; Zaleski A; Nichols WL; Olson JD
J Lab Clin Med; 1994 Aug; 124(2):274-82. PubMed ID: 8051492
[TBL] [Abstract][Full Text] [Related]
15. Platelet-associated anti-glycoprotein (GP) IIb-IIIa autoantibodies in chronic immune thrombocytopenic purpura mainly recognize cation-dependent conformations: comparison with the epitopes of serum autoantibodies.
Kosugi S; Tomiyama Y; Shiraga M; Kashiwagi H; Mizutani H; Kanakura Y; Kurata Y; Matsuzawa Y
Thromb Haemost; 1996 Feb; 75(2):339-45. PubMed ID: 8815587
[TBL] [Abstract][Full Text] [Related]
16. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
[TBL] [Abstract][Full Text] [Related]
17. GPV is a marker of in vivo platelet activation--study in a rat thrombosis model.
Ravanat C; Freund M; Mangin P; Azorsa DO; Schwartz C; Moog S; Schuhler S; Dambach J; Cazenave JP; Lanza F
Thromb Haemost; 2000 Feb; 83(2):327-33. PubMed ID: 10739394
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of antibodies that bind GPIIb/IIIa: antagonist complexes.
Breth L; Kochie J; Combs A; Wang S; Smallheer J; Billheimer J; Seiffert D; Hollis G; O'Neil K
J Immunol Methods; 2005 Jun; 301(1-2):11-20. PubMed ID: 15992818
[TBL] [Abstract][Full Text] [Related]
19. Detection of platelet activation using activation specific monoclonal antibodies.
Metzelaar MJ; Sixma JJ; Nieuwenhuis HK
Blood Cells; 1990; 16(1):85-93; discussion 93-6. PubMed ID: 2190650
[TBL] [Abstract][Full Text] [Related]
20. Anti-GPIIb/IIIa (CD41) monoclonal antibody-induced platelet activation requires Fc receptor-dependent cell-cell interaction.
Anderson GP; van de Winkel JG; Anderson CL
Br J Haematol; 1991 Sep; 79(1):75-83. PubMed ID: 1832937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
